Skip to content
2000
Volume 19, Issue 9
  • ISSN: 1570-159X
  • E-ISSN: 1875-6190

Abstract

Modern-day regulatory systems governing conditions for how health products enter national markets constitute a barrier of access for traditional herbal medicines on an international level. Regulatory intentions are focused on ensuring that consumers are being provided with safe, efficacious and high-quality products that, however, collaterally limit opportunities for traditional herbal medicinal products, especially those that do not already have a long-standing tradition of use established in the respective national marketplaces. This case study investigates and compares how a Southern African herbal medicine with great potential as an anxiolytic and mild antidepressant - Mesembryanthemum tortuosum L. [syn. Sceletium tortuosum (L.) N.E.Br.] aerial parts - fares internationally in today’s regulatory environments. It is argued that inadvertent regulatory favoritism combined with the lack of means for adequate protection of intellectual property may obstruct innovation by creating an almost insurmountable economical hurdle for successful product development and introduction of botanicals from developing countries into most of the world’s health product markets.

Loading

Article metrics loading...

/content/journals/cn/10.2174/1570159X19666210215124737
2021-09-01
2024-12-24
Loading full text...

Full text loading...

/content/journals/cn/10.2174/1570159X19666210215124737
Loading

  • Article Type:
    Review Article
Keyword(s): anxiety; depression; Mesembryanthemum tortuosum; regulations; sceletium
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test